| A
pharmaceutical firm was interested in broadening its portfolio
to other product segments, including allied, non-pharmaceutical
products, and, potentially, targeted medical devices. Other
criteria included increasing margins and expanding geographic scope
to enable cross selling opportunities.
Vericours
helped determine specific acquisition criteria and identified a
series of promising product market segments. Once specific
product market segments were chosen through a strategic
options workshop with the client, we identified a series of possible
acquisition candidates and valuation models and
the acquiree value propositions for each. We then ranked
the candidates with the client and provided support in approaching
the targeted firms. When firms indicated interest,
we supported subsequent negotiations and regulatory filings where
necessary.
After each
successful acquisition we provided post merger integration support
for firms located in the US and Europe. We also
created cross selling strategies where appropriate and accompanying
implementation plans. Where evident, we identified key barriers
to success, such as lack of access by current sales
force or channel and key sales training needs.
|